Theros CancerTYPE ID^® - Increased Accuracy of Tumor Classification

The Challenges of an Accurate Classification

Often when cancer is identified, the primary origin of the cancer is clear and treatment can begin quickly. However, for some patients, initial diagnostic workup yields an indeterminate result. The diagnostic workup for metastatic patients with uncertain primaries can be cumbersome, lengthy, and costly, averaging nearly $18,000.⁴ Even after the most thorough clinical workup, accurate identification of the primary cancer site is often not possible.

Theros CancerTYPE ID can assist with differential diagnoses that dramatically alter therapeutic options by identifying the site of origin for cancer. Some common examples include, but are not limited to:

• Lung (primary) vs. metastatic adenocarcinoma of colon.
• Mesothelioma vs. lung primary vs. metastatic adenocarcinoma of breast.
• Hepatocellular or hepatobiliary (primary) vs. metastatic adenocarcinoma of the pancreas.
• Breast vs. ovarian.
• Pancreatic vs. other GI.
• Ovarian vs. colorectal.